COVID-19

Scientists say the best treatment for COVID-19 may be a cocktail of medicines

06/04/2020

Excerpt from the article: “More than a dozen drug firms in Massachusetts are urgently searching for a medicine to treat COVID-19, but the most potent therapy may not end up being a single medication. Instead, medical experts say, the most effective way to battle the disease will likely be a combination of drugs taken together.…

Read More

First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development

06/03/2020

Excerpt from the article: “Newswise — LA JOLLA, CA—Scientists around the world are racing to develop a vaccine to protect against COVID-19 infection, and epidemiologists are trying to predict how the coronavirus pandemic will unfold until such a vaccine is available. Yet, both efforts are surrounded by unresolved uncertainty whether the immune system can mount…

Read More

The Post-COVID-19 Clinical Trial: Finally Understanding the Meaning of Patient Centricity

06/02/2020

Excerpt from the article: “Lessons Learned from a Virtual Town Hall held on May 8, 2020 Much of the daily news focus is on the race to produce vaccines and therapies to combat the spread of COVID-19. While this work is undeniably important, we mustn’t lose sight of what keeps our industry running: the patients…

Read More

ProMIS Neurosciences identifies multiple novel targets on SARS CoV-2 for development of a highly accurate COVID-19 antibody test

06/01/2020

Excerpt from the article: “TORONTO, Ontario and CAMBRIDGE, Mass., May 12, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a company with unique, core technology to predict novel targets on the molecular surface of complex proteins, has advanced its program to develop a high-throughput, highly accurate test for detection of antibodies to…

Read More

eCOVID Platform Provides Remote Patient Monitoring

05/28/2020

Excerpt from the article: “Engineers at the University of California San Diego have developed a remote monitoring platform for patients who have tested positive for COVID-19 but aren’t in need of hospitalization. The system is being tested by patients in a clinical trial at UC San Diego Health. It is intended to help health care…

Read More

Preventing ‘cytokine storm’ may ease severe COVID-19 symptoms

05/27/2020

Excerpt from the article: “For some COVID-19 patients, the body’s immune response may be as destructive as the virus that causes the disease. The persistent high fevers, severe respiratory distress, and lung damage seen in some critically ill patients are all signs of an immune system in overdrive. Now, a new clinical trial will test…

Read More

Study: Remdesivir benefits some COVID-19 patients

05/26/2020

Excerpt from the article: “A study published late last week in the New England Journal of Medicine found that hospitalized COVID-19 patients who received Gilead Sciences’ antiviral drug remdesivir recovered a median of 4 days earlier than those who received a placebo. Preliminary findings from the double-blind Adaptive COVID-19 Treatment Trial (ACTT-1), sponsored by the…

Read More

Chest x-rays in the ER predict COVID-19 severity

05/20/2020

Excerpt from the Article: “The study findings demonstrate x-ray’s value in helping physicians identify, triage, and treat high-risk patients, wrote a team led by Dr. Danielle Toussie of Mount Sinai Hospital in New York City. “We demonstrate how valuable x-rays can be during this pandemic because, by evaluating disease in different portions of the lungs, we…

Read More

COVID-19 can be seen on CT scans outside the chest

05/19/2020

These findings may well change how future screening for COVID-19 infections is conducted. Excerpt from the article: “The study results suggest that radiologists must keep in mind that patients with COVID-19 can initially present with symptoms other than respiratory ones but still have the disease, wrote a team led by Dr. Rydhwana Hossain of the University…

Read More

Finding Our Way Out: How Science Can Overcome the COVID-19 Crisis

05/18/2020

Gladstone President Emeritus Sandy Williams explains how Gladstone scientists are leveraging their existing research to address the COVID-19 pandemic. Continue Reading The Article

Read More